Clinical Trial Update: International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 open-label randomized trial comparing monthly Ozarelix to Goserelin Depot in men with prostate cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Goserelin Depot (goserelin depot)
• Ozarelix (ozarelix)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED